[1]
|
Small Jr., W., Bacon, M.A., Bajaj, A., et al. (2017) Cervical Cancer: A Global Health Crisis. Cancer, 123, 2404-2412. https://doi.org/10.1002/cncr.30667
|
[2]
|
Giroux, V. and Rustgi, A.K. (2017) Metaplasia: Tissue Injury Adaptation and a Precursor to the Dysplasia-Cancer Sequence. Nature Reviews Cancer, 17, 594-604. https://doi.org/10.1038/nrc.2017.68
|
[3]
|
方三高, 魏建国, 陈真伟. WHO (2020)女性生殖系统肿瘤分类[J]. 诊断病理学杂志, 2021, 28(2): 142-148.
|
[4]
|
Cohen, P.A., Jhingran, A., Oaknin, A., et al. (2019) Cervical Cancer. The Lancet (London, England), 393, 169-182. https://doi.org/10.1016/S0140-6736(18)32470-X
|
[5]
|
Xie, X., Song, K., Cui, B., et al. (2018) A Comparison of the Prognosis between Adenocarcinoma and Squamous Cell Carcinoma in Stage IB-IIA Cervical Cancer. International Journal of Clinical Oncology, 23, 522-531. https://doi.org/10.1007/s10147-017-1225-8
|
[6]
|
Stolnicu, S., Barsan, I., Hoang, L., et al. (2018) International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix. The American Journal of Surgical Pathology, 42, 214-226. https://doi.org/10.1097/PAS.0000000000000986
|
[7]
|
Roma, A.A., Diaz De Vivar, A., Park, K.J., et al. (2015) Invasive Endocervical Adenocarcinoma: A New Pattern-Based Classification System with Important Clinical Significance. The American Journal of Surgical Pathology, 39, 667-672. https://doi.org/10.1097/PAS.0000000000000986
|
[8]
|
Rutgers, J.K.L., Roma, A.A., Park, K.J., et al. (2016) Pattern Classification of Endocervical Adenocarcinoma: Reproducibility and Review of Criteria. Modern Pathology, 29, 1083-1094. https://doi.org/10.1038/modpathol.2016.94
|
[9]
|
Roma, A.A., Mistretta, T.A., Vivar, A.D.D., et al. (2016) New Pattern-Based Personalized Risk Stratification for Endocervical Adenocarcinoma with Important Clinical Implications and Surgical Outcome. Gynecologic Oncology, 141, 36-42. https://doi.org/10.1016/j.ygyno.2016.02.028
|
[10]
|
Zikan, M., Fischerova, D., Pinkavova, I., et al. (2015) A Prospective Study Examining the Incidence of Asymptomatic and Symptomatic Lymphoceles Following Lymphadenectomy in Patients with Gynecological Cancer. Gynecologic Oncology, 137, 291-298. https://doi.org/10.1016/j.ygyno.2015.02.016
|
[11]
|
Mehra, G., Weekes, A., Vantrappen, P., et al. (2010) Laparoscopic Assisted Radical Vaginal Hysterectomy for Cervical Carcinoma: Morbidity and Long-Term Follow-Up. European Journal of Surgical Oncology, 36, 304-308. https://doi.org/10.1016/j.ejso.2009.08.009
|
[12]
|
Wang, W., Song, G., Lin, J., et al. (2019) Study of the Revisited, Revised, and Expanded Silva Pattern System for Chinese Endocervical Adenocarcinoma Patients. Human Pathology, 84, 35-43. https://doi.org/10.1016/j.humpath.2018.08.029
|
[13]
|
Zhang, H.S., Postigo, A.A. and Dean, D.C. (1999) Active Transcriptional Repression by the Rb-E2F Complex Mediates G1 Arrest Triggered by P16INK4a, TGFβ, and Contact Inhibition. Cell, 97, 53-61. https://doi.org/10.1016/S0092-8674(00)80714-X
|
[14]
|
Klaes, R., Friedrich, T., Spitkovsky, D., et al. (2001) Overexpression of P16INK4a as a Specific Marker for Dysplastic and Neoplastic Epithelial Cells of the Cervix Uteri. International Journal of Cancer, 92, 276-284. https://doi.org/10.1002/ijc.1174
|
[15]
|
Sarwath, H., Bansal, D., Husain, N.E., et al. (2017) Introduction of P16INK4a as a Surrogate Biomarker for HPV in Women with Invasive Cervical Cancer in Sudan. Infectious Agents and Cancer, 12, Article No. 50. https://doi.org/10.1186/s13027-017-0159-0
|
[16]
|
Lee, S., Sahasrabuddhe, V.V., Mendoza-Cervantes, D., et al. (2017) Tissue-Based Immunohistochemical Biomarker Expression in Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists, 36, 310-322. https://doi.org/10.1097/PGP.0000000000000345
|
[17]
|
Tringler, B., Gup, C.J., Singh, M., et al. (2004) Evaluation of P16INK4a and pRb Expression in Cervical Squamous and Glandular Neoplasia. Human Pathology, 6, 689-696. https://doi.org/10.1016/j.humpath.2004.02.012
|
[18]
|
Li, Y., Zhang, M.C., Xu, X.K., et al. (2019) Functional Diversity of p53 in Human and Wild Animals. Frontiers in Endocrinology, 10, Article No. 152. https://doi.org/10.3389/fendo.2019.00152
|
[19]
|
Olivier, M., Hollstein, M. and Hainaut, P. (2010) TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use. Cold Spring Harbor Perspectives in Biology, 2, A001008. https://doi.org/10.1101/cshperspect.a001008
|
[20]
|
Petitjean, A., Mathe, E., Kato, S., et al. (2007) Impact of Mutant p53 Functional Properties on TP53 Mutation Patterns and Tumor Phenotype: Lessons from Recent Developments in the IARC TP53 Database. Human Mutation, 28, 622-629. https://doi.org/10.1002/humu.20495
|
[21]
|
Nicolas, M., Wolfer, A., Raj, K., et al. (2003) Notch1 Functions as a Tumor Suppressor in Mouse Skin. Nature Genetics, 33, 416-421. https://doi.org/10.1038/ng1099
|
[22]
|
Talora, C., Sgroi, D.C., Crum, C.P., et al. (2002) Specific Down-Modulation of Notch1 Signaling in Cervical Cancer Cells Is Required for Sustained HPV-E6/E7 Expression and Late Steps of Malignant Transformation. Genes & Development, 16, 2252-2263. https://doi.org/10.1101/gad.988902
|
[23]
|
Yugawa, T., Handa, K., Narisawa-Saito, M., et al. (2007) Regulation of Notch1 Gene Expression by p53 in Epithelial Cells. Molecular and Cellular Biology, 27, 3732-3742. https://doi.org/10.1128/MCB.02119-06
|
[24]
|
Narisawa-Saito, M., Handa, K., Yugawa, T., et al. (2007) HPV16 E6-Mediated Stabilization of ErbB2 in Neoplastic Transformation of Human Cervical Keratinocytes. Oncogene, 26, 2988-2996. https://doi.org/10.1038/sj.onc.1210118
|
[25]
|
Yang, A., Kaghad, M., Wang, Y., et al. (1998) P63, a p53 Homolog at 3q27-29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities. Molecular Cell, 2, 305-316. https://doi.org/10.1016/S1097-2765(00)80275-0
|
[26]
|
Pozzi, S., Zambelli, F., Merico, D., et al. (2009) Transcriptional Network of p63 in Human Keratinocytes. PLOS ONE, 4, e5008. https://doi.org/10.1371/journal.pone.0005008
|
[27]
|
Senoo, M., Pinto, F., Crum, C.P., et al. (2007) P63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia. Cell, 129, 523-536. https://doi.org/10.1016/j.cell.2007.02.045
|
[28]
|
Barbieri, C.E. and Pietenpol, J.A. (2006) P63 and Epithelial Biology. Experimental Cell Research, 312, 695-706. https://doi.org/10.1016/j.yexcr.2005.11.028
|
[29]
|
Vosmik, M., Laco, J., Sirak, I., et al. (2014) Prognostic Significance of Human Papillomavirus (HPV) Status and Expression of Selected Markers (HER2/Neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on Outcome after (Chemo-) Radiotherapy in Patients with Squamous Cell Carcinoma of Uterine Cervix. Pathology & Oncology Research, 20, 131-137. https://doi.org/10.1007/s12253-013-9674-5
|
[30]
|
Kaufmann, O., Fietze, E., Mengs, J., et al. (2001) Value of p63 and Cytokeratin 5/6 as Immunohistochemical Markers for the Differential Diagnosis of Poorly Differentiated and Undifferentiated Carcinomas. American Journal of Clinical Pathology, 116, 823-830. https://doi.org/10.1309/21TW-2NDG-JRK4-PFJX
|
[31]
|
金雪梅, 韩龙哲. 免疫组织化学方法检测P16 P13 P40在颈部淋巴结转移性鳞状细胞癌鉴别诊断中的应用[J]. 实用医技杂志, 2016, 23(8): 888-889.
|
[32]
|
杜倩, 赵焕芬, 康林, 等. 肺鳞状细胞癌组织中p63、CK5/6和p40的表达及其病理诊断价值[J]. 现代肿瘤医学, 2019, 27(11): 1907-1910.
|
[33]
|
Kriegsmann, K., Cremer, M., Zgorzelski, C., et al. (2019) Agreement of CK5/6, p40, and p63 Immunoreactivity in Non-Small Cell Lung Cancer. Pathology, 51, 240-245. https://doi.org/10.1016/j.pathol.2018.11.009
|
[34]
|
Pelosi, G., Rossi, G., Cavazza, A., et al. (2013) ΔNp63 (P40) Distribution inside Lung Cancer: A Driver Biomarker Approach to Tumor Characterization. International Journal of Surgical Pathology, 21, 229-239. https://doi.org/10.1177/1066896913476750
|
[35]
|
Bishop, J.A., Teruya-Feldstein, J., Westra, W.H., et al. (2012) P40 (ΔNp63) Is Superior to p63 for the Diagnosis of Pulmonary Squamous Cell Carcinoma. Modern Pathology, 25, 405-415. https://doi.org/10.1038/modpathol.2011.173
|
[36]
|
Ma, Y., Fan, M., Dai, L., et al. (2015) Expression of p63 and CK5/6 in Early-Stage Lung Squamous Cell Carcinoma Is Not Only an Early Diagnostic Indicator but Also Correlates with a Good Prognosis. Thoracic Cancer, 6, 288-295. https://doi.org/10.1111/1759-7714.12181
|
[37]
|
Downey, P., Cummins, R., Moran, M., et al. (2008) If It’s Not CK5/6 Positive, TTF-1 Negative It’s Not a Squamous Cell Carcinoma of Lung. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 116, 526-529. https://doi.org/10.1111/j.1600-0463.2008.00932.x
|
[38]
|
Lee, H., Lee, H. and Cho, Y.K. (2017) Cytokeratin7 and Cytokeratin19 Expression in High Grade Cervical Intraepithelial Neoplasm and Squamous Cell Carcinoma and Their Possible Association in Cervical Carcinogenesis. Diagnostic Pathology, 12, Article No. 18. https://doi.org/10.1186/s13000-017-0609-4
|
[39]
|
李亦明, 王贵明, 龙中华, 等. IHC联合FISH检测胃癌中HER2与CK8/18、P53、CEA的表达及其相关性研究[J]. 诊断病理学杂志, 2019, 26(12): 812-816.
|
[40]
|
Raap, M., Gierendt, L., Werlein, C., et al. (2021) Co-Expression of Transcription Factor AP-2beta (TFAP2B) and GATA3 in Human Mammary Epithelial Cells with Intense, Apicobasal Immunoreactivity for CK8/18. Journal of Molecular Histology, 52, 1257-1264. https://doi.org/10.1007/s10735-021-09980-2
|
[41]
|
Gerdes, J., Schwab, U., Lemke, H., et al. (1983) Production of a Mouse Monoclonal Antibody Reactive with a Human Nuclear Antigen Associated with Cell Proliferation. International Journal of Cancer, 31, 13-20. https://doi.org/10.1002/ijc.2910310104
|
[42]
|
Konishi, I., Fujii, S., Nonogaki, H., et al. (1991) Immunohistochemical Analysis of Estrogen Receptors, Progesterone Receptors, Ki-67 Antigen, and Human Papillomavirus DNA in Normal and Neoplastic Epithelium of the Uterine Cervix. Cancer, 68, 1340-1350. https://doi.org/10.1002/1097-0142(19910915)68:6<1340::AID-CNCR2820680626>3.0.CO;2-Q
|
[43]
|
Tjalma, W.A.A. (2017) Diagnostic Performance of Dual-Staining Cytology for Cervical Cancer Screening: A Systematic Literature Review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 210, 275-280. https://doi.org/10.1016/j.ejogrb.2017.01.009
|
[44]
|
Silva, D.C., Gonçalves, A.K., Cobucci, R.N., et al. (2017) Immunohistochemical Expression of p16, Ki-67 and p53 in Cervical Lesions—A Systematic Review. Pathology, Research and Practice, 213, 723-729. https://doi.org/10.1016/j.prp.2017.03.003
|
[45]
|
Calil, L.N., Edelweiss, M.I.A., Meurer, L., et al. (2014) P16INK4a and Ki67 Expression in Normal, Dysplastic and Neoplastic Uterine Cervical Epithelium and Human Papillomavirus (HPV) Infection. Pathology—Research and Practice, 210, 482-487. https://doi.org/10.1016/j.prp.2014.03.009
|